Corcept Therapeutics | CORT - Trade Creditors


Corcept Therapeutics reported $14.91M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 44.57M 32.32M Jun/2026
Alaunos Therapeutics USD 400K 213K Mar/2026
ANI Pharmaceuticals USD 69.69M 7.11M Mar/2026
Ardelyx USD 28.2M 8.96M Mar/2026
Aurora Cannabis CAD 9.31M 58.72M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Canopy Growth CAD 34.82M 14.85M Mar/2026
Corcept Therapeutics USD 14.91M 18.4M Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
J&J USD 9.22B 1.24B Jun/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Lexicon Pharmaceuticals USD 3M 87K Mar/2026
Merck USD 3.86B 541M Mar/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Novartis USD 4.26B 64M Jun/2026
Novartis USD 4.32B 134M Mar/2026
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 17.51M 3.5M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Supernus Pharmaceuticals USD 5.59M 4.58M Jun/2026
TG Therapeutics USD 148.84M 41.34M Mar/2026